10-K: Eastman Chemical Reports 2025 Decline in Sales and Earnings Amid Market Headwinds
Annual Report
Eastman Chemical Company reported a 7% decrease in sales and a 39% drop in EBIT for 2025, driven by lower volumes and higher costs, while continuing to advance its molecular recycling and sustainability platforms.
Summary
- Sales revenue for 2025 decreased by 7% to $8,752 million from $9,382 million in 2024.
- Earnings before interest and taxes (EBIT) for 2025 were $776 million, a 39% decrease from $1,278 million in 2024.
- Net earnings attributable to Eastman for 2025 were $474 million, down from $905 million in 2024.
- Diluted earnings per share (EPS) for 2025 were $4.10, compared to $7.67 in 2024.
- Adjusted EBIT (excluding non-core items) for 2025 was $930 million, a 28% decrease from $1,298 million in 2024.
- Adjusted diluted EPS for 2025 was $5.42, down from $7.89 in 2024.
- Cash provided by operating activities decreased to $970 million in 2025 from $1,287 million in 2024.
- The decline in sales and EBIT was primarily due to lower sales volume, lower selling prices, higher raw material and energy costs, and lower asset utilization.
- The world's largest polyester molecular recycling facility, which began operating in 2024, achieved approximately 2.5 times greater output in 2025 compared to 2024.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this filing with a negative sentiment due to significant year-over-year declines in key financial metrics (sales, EBIT, net earnings, EPS) and increased asset impairments. While strategic investments in sustainability and cost reduction efforts are noted, they have not yet offset the impact of market headwinds and the termination of a key growth project.
Positives
- The world's largest polyester molecular recycling facility achieved strong improvement in operating rates in 2025, generating approximately 2.5 times greater output than 2024.
- Continued adoption of circular polyester offerings across multiple end-markets, including consumer durables and packaging, demonstrates market acceptance of sustainable solutions.
- Cost reduction initiatives and lower variable compensation costs partially offset negative financial trends, indicating effective internal management efforts.
- The Additives & Functional Products segment saw growth in water treatment, medical and pharma, and electronics end-markets.
- Strategic investment in innovation led to a slight increase in R&D expenses, signaling continued commitment to future growth.
- The Credit Facility was amended to extend its maturity to February 2031, enhancing financial flexibility and liquidity.
Negatives
- Sales revenue decreased by 7% in 2025 compared to 2024, reflecting broad market weakness.
- EBIT decreased by 39% in 2025 compared to 2024, indicating significant pressure on profitability.
- Net earnings attributable to Eastman decreased by 47.6% to $474 million in 2025 from $905 million in 2024.
- Diluted EPS decreased by 46.5% to $4.10 in 2025 from $7.67 in 2024.
- Lower sales volume was driven by acetate tow customer inventory destocking, industry capacity share adjustments, and weak consumer discretionary spending in most end markets.
- Higher raw material and energy costs negatively impacted gross profit and EBIT.
- Lower asset utilization contributed to reduced profitability.
- The Advanced Materials segment experienced lower sales volume due to weakness in the building and construction and automotive end-markets.
- The Chemical Intermediates segment's sales decreased due to lower sales volume and competitive pressure in Asia.
- The Fibers segment's sales revenue decreased by 20% due to lower acetate tow sales volume (customer inventory destocking and capacity adjustments) and reduced textiles sales into Europe and Asia (tariffs).
- Net cash provided by operating activities decreased by $317 million in 2025 compared to 2024.
- Asset impairments, restructuring, and other charges, net increased to $96 million in 2025 from $51 million in 2024.
- Net interest expense increased by 4% in 2025, primarily due to lower interest income and lower capitalized interest.
Risks
- Continued uncertain conditions in the global economy, labor market, and financial markets, including heightened inflation, capital market volatility, interest rate and currency fluctuations, and economic slowdown or recession, could negatively impact the Company.
- Volatility in costs for strategic raw material and energy commodities or disruption in their supply and transportation, as well as in the transportation of Company products, could adversely impact financial results.
- Prolonged periods of heightened inflation or supply chain disruptions could have a material, adverse impact on financial performance.
- Substantial global operations subject the Company to risks of doing business in other countries, including fluctuations in currency exchange rates, trade restrictions, and political instability.
- Operating risks common to chemical and specialty materials manufacturing businesses, such as explosions, fires, natural disasters, mechanical failure, unscheduled downtime, and chemical spills, could disrupt operations.
- Risks related to information technology infrastructure, including service interruptions, data corruption, cyber-based attacks, or network security incidents, could disrupt operations or impair data confidentiality.
- Risks associated with the potential use of artificial intelligence (AI) in the Company's own operations and by third-party partners, such as unauthorized data disclosure, inaccurate analyses, or bias, could result in reputational harm or legal liability.
- Growth initiatives, including sustainable innovation and molecular recycling, may not achieve desired business or financial objectives and may require significant resources in excess of estimates.
- The Company is subject to various legal proceedings and may be subject to future claims (e.g., product liability, asbestos, environmental) that could have a material adverse effect.
- Inability to protect intellectual property rights could adversely impact the Company's competitive position.
- Significant acquisitions or divestitures could expose the Company to risks such as worse than expected financial performance, asset impairments, increased costs, delays in achieving synergies, or loss of management focus.
- Indemnity claims relating to properties or businesses divested or acquired could adversely affect financial condition.
- Failure to attract and retain talented personnel could adversely affect the Company's ability to compete and achieve strategic objectives.
- Legislative, regulatory, or voluntary actions, or violations thereof, could increase future health, safety, environmental, and other compliance costs and legal costs.
- Financial, regulatory, physical, and transition risks associated with climate change, including extreme weather events and new carbon requirements, could materially adversely affect the business.
- Changes in tax laws, regulations, or treaties or adverse determinations by taxing authorities (e.g., OECD global minimum tax) could increase tax liabilities.
- The Company's insurance may not fully cover all potential exposures, leading to material adverse effects from uninsured or underinsured events.
- Loss of certain top customers could adversely affect the Company, as the top 100 customers accounted for approximately 60% of 2025 sales revenue.
Future Outlook
Management anticipates continued stable cash flow generation, a strong balance sheet, and sufficient liquidity to support future growth initiatives. Capital spending for 2026 is projected to be approximately $400 million, primarily allocated to maintenance and ongoing growth projects. The Company does not foresee near-term environmental capital expenditures materially impacting its planned annual capital spending for environmental control facilities. Volatility in raw material and energy prices is expected to persist, with the Company planning to continue utilizing pricing, hedging, and cost control strategies to mitigate these effects. The Credit Facility's maximum leverage ratio covenant has been temporarily adjusted through June 30, 2027, to account for potential macroeconomic uncertainty.
Management Comments
- "Management believes that these elements of the Company's innovation-driven growth model, combined with disciplined portfolio management and balanced capital deployment, are transforming Eastman into a global specialty materials company that enhances the quality of life in a material way."
- "Management believes that this innovation-driven growth model will enable the Company to leverage its proven technology capabilities to improve product mix, increasing emphasis on specialty businesses, and sustaining and expanding market share through leadership in attractive targeted markets."
- "Management believes maintaining a financial profile that supports a solid investment grade credit rating is important to its long-term strategy and financial flexibility."
- "Management believes the AM segment's competitive advantages also include long-term customer relationships, vertical integration and scale in manufacturing, and leading market positions."
- "Management believes that the ability to leverage the AFP segment's research, differentiated application development, and production capabilities across multiple markets uniquely positions it to meet evolving needs to improve the quality and performance of its customers' products."
Industry Context
StockSavvy.ai notes that Eastman Chemical's 2025 performance reflects broader challenges within the chemical and specialty materials industry, including global economic uncertainty, inflationary pressures, and supply chain disruptions. The decline in sales and EBIT, particularly in segments exposed to consumer discretionary spending (Advanced Materials, Fibers), is consistent with a cautious consumer environment. However, the company's continued investment in molecular recycling and circular economy solutions aligns with a significant industry trend towards sustainability and could position it favorably for long-term growth as demand for eco-friendly materials increases.
Comparison to Industry Standards
- StockSavvy.ai notes that while the filing details Eastman's competitive landscape, it does not provide specific quantitative comparisons of its financial performance or project results against global industry benchmarks or direct competitors like Celanese Corporation or BASF SE. Therefore, a direct assessment of its results against industry standards is limited by the information provided.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Executive Vice President, Chief Technology and Sustainability Officer | Stephen G. Crawford (previously Executive Vice President, Methanolysis Operations and Worldwide Engineering & Construction Transformation) | Stephen G. Crawford | November 2025 | Reassignment of responsibilities |
| Executive Vice President, Additives & Functional Products, Manufacturing, WWE&C and HSE | Travis Smith (previously Senior Vice President with responsibility for the AFP segment) | Travis Smith | January 2025 | Reassignment of responsibilities |
| Senior Vice President, Chief Legal Officer and Corporate Secretary | NA | Ik Adeyemi | September 2024 | Appointment |
| Senior Vice President and Chief Manufacturing Officer | Michelle H. Caveness (previously Vice President, Tennessee operations site leader and global operations support) | Michelle H. Caveness | January 2025 | Reassignment of responsibilities |
| Senior Vice President and Chief Technology and Sustainability Officer | Christopher M. Killian | NA | December 31, 2025 | Retirement |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Credit Facility Amendment | The Credit Facility was amended in December 2025 to remove sustainability-linked pricing terms from the agreement. | December 2025 | Removes specific ESG-linked financial incentives from the credit agreement. |
| Credit Facility Amendment and Restatement | The Credit Facility was amended and restated to extend the maturity to February 2031 and to temporarily adjust the maximum leverage ratio covenant through the fiscal quarter ending June 30, 2027, in the event of further macroeconomic uncertainty impacting operating results. | February 2026 | Enhances long-term financial flexibility and provides temporary relief on leverage covenants during periods of economic uncertainty. |
| Policy Adoption | The Eastman Chemical Company Compensation Clawback Policy for Detrimental Conduct was adopted by the Compensation and Management Development Committee. | December 4, 2024 | Strengthens corporate governance by allowing the company to recover incentive-based compensation in cases of detrimental conduct. |
| Policy Adoption | The Eastman Chemical Company Incentive Pay Clawback Policy was adopted by the Compensation and Management Development Committee. | October 4, 2023 | Enhances accountability by allowing recovery of incentive-based compensation following accounting restatements. |
| Oversight Structure | The Board of Directors provides oversight of the Company's cybersecurity program, with the Audit Committee receiving updates from the Chief Information Officer or Chief Information Security Officer at least quarterly. | Ongoing | Ensures robust oversight of cybersecurity risks and strategies at the highest level of governance. |
| Oversight Structure | A cross-functional Responsible AI Council oversees AI use cases, sets standards, and coordinates with existing risk and compliance functions. | Ongoing | Establishes a structured approach to managing risks associated with the increasing use of artificial intelligence. |
Legal Proceedings
- The Company is involved in various legal proceedings, including product liability, personal injury, asbestos, patent and intellectual property, commercial, contract, environmental, antitrust, health and safety, and employment matters, which are handled in the ordinary course of business.
- In the Solutia Legacy Torts Claims Litigation, Monsanto Company (acquired by Bayer AG) is responsible for the defense and indemnification of Solutia (acquired by Eastman in 2012) against Legacy Tort Claims. Eastman guaranteed Solutia's obligations and was added as an indemnified party under the Monsanto Settlement Agreement. Solutia could potentially be liable for claims not falling under Legacy Tort Claims.
Related Party Transactions
- The Company contractually supplies acetate flake raw material to the manufacturing facility of its acetate tow joint venture in China from its Kingsport, Tennessee facility.
- Eastman owns a 50% interest in a joint venture for the manufacture of compounded cellulose diacetate in Shenzhen, China.
- Eastman owns a 45% interest in a joint venture with China National Tobacco Corporation that manufactures acetate tow in Hefei, China.
- Equity investments include a 40% interest in a joint venture facility in Kingsport, Tennessee that manufactures acetylated wood.
- Confirmed obligations in the Company's voluntary supplier finance program and structured payables program totaled $110 million at December 31, 2025.
Stakeholder Impact
- **Shareholders**: Experienced a significant decline in net earnings and diluted EPS in 2025. However, the company continues to return value through quarterly dividends ($3.33 per share in 2025) and share repurchases ($100 million in 2025). The extension of the credit facility maturity provides financial stability.
- **Employees**: The company emphasizes employee health, safety, and well-being with a 'zero-incident mindset' and offers competitive compensation and benefits. Severance charges were incurred due to corporate cost reduction initiatives, indicating some workforce adjustments.
- **Customers**: The company is focused on delivering innovative and sustainable products, but experienced lower sales volumes due to weak consumer discretionary spending and competitive pressures in certain end-markets. Supply chain challenges also impacted product distribution.
- **Suppliers**: The company utilizes off-balance sheet accounts receivable factoring programs and a voluntary supplier finance program to optimize payment terms and cash flows, which can impact supplier liquidity and relationships.
- **Creditors**: The company maintains a strong financial profile to support an investment-grade credit rating. Total borrowings were $4.8 billion, and the credit facility was amended to extend maturity and temporarily adjust leverage ratio covenants, providing flexibility in managing debt obligations.
Next Steps
- Continue to pursue growth opportunities through both organic and inorganic initiatives, including sustainable innovation.
- Leverage molecular recycling technologies to enable various waste plastics to be recycled into specialty plastics products marketed under the 'Renew' designation.
- Expand the portfolio of higher margin products in attractive end-markets within the Advanced Materials segment.
- Maintain focus on cost control, operational efficiency, and capacity utilization in the Chemical Intermediates segment.
- Invest in differentiated application development capabilities and new product innovations, including circular solutions, to drive growth in textiles and apparel of Naia yarns and fibers.
- Project approximately $400 million in capital spending for 2026, primarily for maintenance and limited growth capital for projects already in progress.
- Monitor and evaluate the impacts of the OECD global minimum tax.
- Actively evaluate the impact of the DOE grant termination on the Polyethylene Terephthalate Recycling Decarbonization Project's scope, timeline, and carrying values of associated assets, and prepare a settlement proposal if reinstatement is not obtained.
- The Board of Directors has declared a cash dividend of $0.84 per share during the first quarter of 2026, payable on April 8, 2026, to stockholders of record on March 13, 2026.
Key Dates
| Date | Description |
|---|---|
| 1993-12-31 | Eastman Chemical Company became a public company, incorporated in Delaware. |
| 2004 | Divestiture of resins, inks, and monomers product lines. |
| 2006 | Divestiture of the polyethylene business. |
| 2007 | Beginning of divestiture of polyethylene terephthalate (PET) assets and business (completed by 2010). |
| 2012 | Acquisition of Solutia, Inc. |
| 2012-07-02 | Completion of Eastman's acquisition of Solutia. |
| 2014 | Acquisition of Taminco Corporation. |
| 2014-01 | Mark J. Costa appointed Chief Executive Officer. |
| 2014-07 | Mark J. Costa named Board Chair. |
| 2020-02 | William T. McLain, Jr. appointed Executive Vice President and Chief Financial Officer. |
| 2021-12 | Board of Directors authorized the repurchase of up to $2.5 billion of the Company's outstanding common stock. |
| 2023-12-01 | Completion of the sale of the Company's Texas City operations. |
| 2024 | Eastman began operating the world's largest polyester molecular recycling facility. |
| 2024-01-01 | Effective date for OECD global minimum tax laws in several jurisdictions. |
| 2024-02-20 | Form of 5.625% Note due 2034. |
| 2024-08-01 | Form of 5.0% Note due 2029. |
| 2024-09 | Ik Adeyemi appointed Senior Vice President, Chief Legal Officer and Corporate Secretary. |
| 2024-12-04 | Eastman Chemical Company Compensation Clawback Policy for Detrimental Conduct adopted by the Committee. |
| 2024-12-31 | Fiscal year end for 2024. |
| 2025-01-01 | Adoption of ASU 2023-05 (Business Combination Joint Venture Formations) and ASU 2023-09 (Income Taxes Improvements to Income Tax Disclosures). |
| 2025-01 | Travis Smith appointed Executive Vice President, Additives & Functional Products, Manufacturing, WWE&C and HSE. |
| 2025-01 | Michelle H. Caveness appointed Senior Vice President and Chief Manufacturing Officer. |
| 2025-02-21 | Form of 5.000% Note due 2029. |
| 2025-05-29 | DOE terminated an award related to the Polyethylene Terephthalate Recycling Decarbonization Project. |
| 2025-11 | Stephen G. Crawford appointed Executive Vice President, Chief Technology and Sustainability Officer. |
| 2025-12 | Credit Facility amended to remove sustainability-linked pricing terms. |
| 2025-12-31 | Fiscal year end for 2025. |
| 2026-01-05 | OECD's 'side by side' arrangement for global minimum tax. |
| 2026-02-12 | Fourth Amended and Restated Five-Year Credit Agreement dated. |
| 2026-02-13 | Date of filing of the Annual Report on Form 10-K. |
| 2026-03-13 | Record date for the cash dividend of $0.84 per share declared for Q1 2026. |
| 2026-04-08 | Payment date for the cash dividend of $0.84 per share declared for Q1 2026. |
| 2027-06-30 | Temporary adjustment to the maximum leverage ratio covenant through this fiscal quarter. |
| 2031-02 | Extended maturity date for the Credit Facility. |
| 2032 | Expected year for health care cost trend to decrease to an ultimate trend of 5.00%. |
| 2035 | Commitment to reduce absolute scope 1 and scope 2 emissions by 30% by this year. |
| 2050 | Commitment to achieve net-zero operations by this year. |
Recommendation
sellThe substantial year-over-year declines in sales, EBIT, and net earnings, alongside increased asset impairments and the termination of a significant DOE grant for a molecular recycling project, indicate deteriorating financial performance and increased operational headwinds. While the company highlights strategic investments in sustainability and cost reduction, these efforts have not yet translated into improved financial results. The negative trends across multiple segments and the macroeconomic uncertainties suggest a challenging outlook, warranting a 'sell' recommendation for investors seeking stronger performance and lower risk.
Keywords
Eastman Chemical, Specialty Materials, Molecular Recycling, Sustainability, 10-K, Financial Performance, Chemical Industry, Advanced Materials, Additives & Functional Products, Chemical Intermediates, Fibers, ESG, Circular Economy, Earnings, EBIT, EPS, Risk Factors
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.